Log In
BCIQ
Print this Print this
 

Alferon LDO

  Manage Alerts
Collapse Summary General Information
Company Hemispherx Biopharma Inc.
DescriptionLow-dose interferon (IFN) alpha-n3
Molecular Target Type I interferon (IFN) receptor
Mechanism of ActionType I interferon (IFN) receptor agonist
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today